Sweden's medical landscape includes lorazepam, a benzodiazepine used to treat anxiety and associated illnesses. Sweden, like many other nations, prescribes lorazepam to treat anxiety, panic attacks, and insomnia.

Due to its propensity for dependence and withdrawal, Sweden's healthcare system prescribes lorazepam for short-term usage. The Swedish Medical Products Agency (MPA) supervises such pharmaceuticals to guarantee proper prescribing and patient education.

Benzodiazepines like lorazepam are debated and researched worldwide, particularly for their long-term effects and addiction risk. In accordance with a holistic approach to patient well-being, the Swedish healthcare system emphasizes cognitive-behavioral therapy and other non-pharmacological therapies for anxiety and related illnesses